Evidence map›Paper›PMID 31214278›Full record

ArticleOxidative medicine and cellular longevity2019

Joseph Iharinjaka Randriamboavonjy, Sandrine Heurtebise, Pierre Pacaud, Gervaise Loirand, Angela Tesse

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Biomolecules & biomedicine · 2026
    Review
  2. The Effect ofFood science & nutrition · 2026
    Review
  3. Review
  4. Nutrients · 2025
    Review
  5. Suppression of Inflamm-Aging byMolecules (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Potency ofFrontiers in pharmacology · 2021
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph Iharinjaka RandriamboavonjyL'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.ORCID 0000-0002-0367-3564
Sandrine HeurtebiseL'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.
Pierre PacaudL'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.
Gervaise LoirandL'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.ORCID 0000-0002-2306-3931
Angela TesseL'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.ORCID 0000-0002-2153-4357
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular aging is characterized by functional and structural changes of the vessel wall, including endothelial dysfunction, with decreased endothelial NO

Indexed as

Moringa oleiferaAgingAnimalsAortaCardiovascular DiseasesCells, CulturedDietary SupplementsEndotheliumHumansMaleMyocardial ContractionNitric Oxide SynthaseProto-Oncogene Proteins c-aktRatsRats, WistarSeedsNitric Oxide SynthaseProto-Oncogene Proteins c-akt

Identifiers

PMID31214278
PMCPMC6535829
OpenAlexW2946241298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.